Trademark: 90788287
Status Date
Tuesday, August 1, 2023
Registration Number
7123802
Registration Date
Tuesday, August 1, 2023
Filing Date
Tuesday, June 22, 2021
Published for Opposition
Tuesday, February 28, 2023
5 Viral systems, gene therapy systems, nucleic acid delivery systems, viral vectors, non-viral vectors, gene therapy vectors, nucleic acid delivery vectors, and cells transformed by viral vectors, non-viral vectors, gene therapy vectors or nucleic acid delivery vectors for medical purposes, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; pharmaceutical products for the treatment of viral diseases; biological preparations for use in medical and clinical gene therapy, nucleic acid-based therapy and cell therapy, namely, biological preparations for medical diagnostic or treatment use; clinical medical reagents for use in nucleic acid-based therapy, gene therapy, cell therapy, gene diagnosis and gene testing, namely, reagents for medical use; pharmaceutical preparations, vaccines, prophylaxis products and other products for use in nucleic acid-based therapy, gene therapy and cell therapy
44 Gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation for the treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, inflammatory and auto-immune diseases, vascular disorders, inherited disorders, genetic disorders and single gene disorders; Consultancy in the field of pharmaceutics
42 Research, product development and consultancy in the field of biotechnology, biologic pharmaceutical preparations, medical science, chemistry and biochemistry; Research and product development in the field of pharmaceutics
Aug 1, 2023
Notice Of Registration Confirmation Emailed
Aug 1, 2023
Registered-Principal Register
Jun 26, 2023
1(B) Basis Deleted; Proceed To Registration
May 1, 2023
Notice Of Allowance Cancelled
Jun 26, 2023
Case Assigned To Intent To Use Paralegal
May 1, 2023
Teas Delete 1(B) Basis Received
Apr 25, 2023
Noa E-Mailed - Sou Required From Applicant
Feb 28, 2023
Official Gazette Publication Confirmation E-Mailed
Feb 28, 2023
Published For Opposition
Feb 8, 2023
Notification Of Notice Of Publication E-Mailed
Jan 23, 2023
Electronic Record Review Complete
Jan 20, 2023
On Hold - Electronic Record Review Required
Jan 19, 2023
Approved For Pub - Principal Register
Jan 10, 2023
Teas/Email Correspondence Entered
Jan 9, 2023
Correspondence Received In Law Office
Jan 9, 2023
Teas Response To Office Action Received
Nov 14, 2022
Notification Of Non-Final Action E-Mailed
Nov 14, 2022
Non-Final Action E-Mailed
Nov 14, 2022
Non-Final Action Written
Oct 24, 2022
Previous Allowance Count Withdrawn
Sep 6, 2022
Withdrawn From Pub - Og Review Query
Aug 22, 2022
Approved For Pub - Principal Register
Jul 29, 2022
Teas/Email Correspondence Entered
Jul 29, 2022
Correspondence Received In Law Office
Jul 28, 2022
Assigned To Lie
Jul 26, 2022
Teas Response To Suspension Inquiry Received
Jul 20, 2022
Teas Change Of Correspondence Received
Jul 20, 2022
Teas Change Of Domestic Representatives Address
Jul 20, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 20, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Feb 10, 2022
Notification Of Letter Of Suspension E-Mailed
Feb 10, 2022
Letter Of Suspension E-Mailed
Feb 10, 2022
Suspension Letter Written
Feb 8, 2022
Assigned To Examiner
Sep 9, 2021
Preliminary/Voluntary Amendment - Entered
Sep 9, 2021
Assigned To Lie
Jun 25, 2021
Teas Voluntary Amendment Received
Sep 7, 2021
New Application Office Supplied Data Entered
Jun 25, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
